ViAqua Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $10M

  • Investors
  • 12

ViAqua Therapeutics General Information

Description

Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection and delivers the coated nanoparticles via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other aquaculture species.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Aquaculture
Other Industries
Other Commercial Services
Biotechnology
Corporate Office
  • Post Office Box 5055
  • Kadima Zoran 6092000
  • Israel
+972 00-000-0000

ViAqua Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ViAqua Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 05-Sep-2023 $10M 000.00 000.00 Completed Generating Revenue
4. Later Stage VC 09-Jun-2021 00.00 00.000 00.000 Completed Generating Revenue
3. Early Stage VC 18-Dec-2018 000 00.000 000 Completed Generating Revenue
2. Early Stage VC 04-Jul-2018 $290K $290K 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view ViAqua Therapeutics’s complete valuation and funding history, request access »

ViAqua Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
A-1 Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
Seed Shares 56,000 $0.010000 $53.83 $53.83 1x $53.83 6.21%
Seed-1 Shares 7,000 $0.010000 $43.07 $43.07 1x $43.07 0.75%
To view ViAqua Therapeutics’s complete cap table history, request access »

ViAqua Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics
Aquaculture
Kadima Zoran, Israel
14 As of 2023
000.00
000.00 0000-00-00
0000000000 0 000.00

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
0000 000000000
Leuven, Belgium
00 As of 0000
000.00
000.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViAqua Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ViroVet Venture Capital-Backed Leuven, Belgium 00 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

ViAqua Therapeutics Patents

ViAqua Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10973774-B2 Compositions and methods for treating viral infections in shrimps Active 26-Apr-2016 0000000000 00
US-20190175518-A1 Compositions and methods for treating viral infections in shrimps Active 26-Apr-2016 0000000000

ViAqua Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Shai Ufaz Ph.D Co-Founder & Chief Executive Officer
Shai Einbinder Ph.D Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »

ViAqua Therapeutics Board Members (2)

Name Representing Role Since
Chris Beattie Ph.D Self Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

ViAqua Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViAqua Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Circle Investments LLC Venture Capital Minority 000 0000 000000 0
I-Lab Angels Angel Group Minority 000 0000 000000 0
Rabo Ventures Venture Capital Minority 000 0000 000000 0
Agriline Corporation Minority 000 0000 000000 0
S2G Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

ViAqua Therapeutics FAQs

  • When was ViAqua Therapeutics founded?

    ViAqua Therapeutics was founded in 2014.

  • Who is the founder of ViAqua Therapeutics?

    Shai Ufaz Ph.D and Shai Einbinder Ph.D are the founders of ViAqua Therapeutics.

  • Who is the CEO of ViAqua Therapeutics?

    Shai Ufaz Ph.D is the CEO of ViAqua Therapeutics.

  • Where is ViAqua Therapeutics headquartered?

    ViAqua Therapeutics is headquartered in Kadima Zoran, Israel.

  • What is the size of ViAqua Therapeutics?

    ViAqua Therapeutics has 14 total employees.

  • What industry is ViAqua Therapeutics in?

    ViAqua Therapeutics’s primary industry is Aquaculture.

  • Is ViAqua Therapeutics a private or public company?

    ViAqua Therapeutics is a Private company.

  • What is the current valuation of ViAqua Therapeutics?

    The current valuation of ViAqua Therapeutics is 000.00.

  • What is ViAqua Therapeutics’s current revenue?

    The current revenue for ViAqua Therapeutics is 000000.

  • How much funding has ViAqua Therapeutics raised over time?

    ViAqua Therapeutics has raised $17.6M.

  • Who are ViAqua Therapeutics’s investors?

    Circle Investments LLC, I-Lab Angels, Rabo Ventures, Agriline, and S2G Ventures are 5 of 12 investors who have invested in ViAqua Therapeutics.

  • Who are ViAqua Therapeutics’s competitors?

    ViroVet is a competitor of ViAqua Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »